Texas Heart TV Is Moving

Beginning December 22, 2025, this site will transition to the main Texas Heart Institute website. Our commitment remains unchanged: to advance cardiovascular health through trusted education for patients, clinicians, and the broader medical community.
Live stream preview

Watch this video and more on Texas Heart TV Is Moving

Watch this video and more on Texas Heart TV Is Moving

Subscribe Learn more

Already subscribed? Sign in

Use of Finerenone in Patients with Diabetes Who Have Kidney Disease (.50)

34m

The Texas Heart Institute presents the 12th Annual Women's Heart and Vascular Symposium May 6, 2023.

Register for our upcoming symposia: texasheart.org/education/continuing-medical-education/our-symposia/

Tags
the texas heart institute, THI, Houston, Texas Medical Center, Heart and vascular disease, cme, live cme, women, Guidelines Updates, Risk, Treatment Updates, Stephanie Coulter, George Bakris, Finerenone, Patients, Diabetes, Kidney Disease, sglt2 inhibitors, renal replacement therapy, cardiorenal, holistic approach, assessment and prevention, Women’s Heart and Vascular Symposium
×